Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity

scientific article published in May 2000

Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(00)02222-4
P698PubMed publication ID10821370

P2093author name stringF C Breedveld
R B Landewé
B A Dijkmans
B E van den Borne
P2860cites workNo increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritisQ77539447
Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritisQ35548424
Homocyst(e)ine: an important risk factor for atherosclerotic vascular disease.Q41452120
Abnormal homocysteine metabolism in rheumatoid arthritisQ61663327
P433issue9215
P407language of work or nameEnglishQ1860
P921main subjectcirculatory systemQ11068
methotrexateQ422232
rheumatoid arthritisQ187255
comorbidityQ1414874
P304page(s)1616-1617
P577publication date2000-05-01
P1433published inThe LancetQ939416
P1476titleMethotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity
P478volume355

Reverse relations

cites work (P2860)
Q28188829A clinical and economic review of disease-modifying antirheumatic drugs
Q51787678Accelerated atherosclerosis in pre-menopausal female patients with rheumatoid arthritis.
Q34601733Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?
Q59329753An interpretable boosting model to predict side effects of analgesics for osteoarthritis
Q37436281Assessment of left atrial mechanical functions and atrial electromechanical delay in Juvenile idiopathic arthritis by tissue Doppler echocardiography
Q43578147Association between systemic antipsoriatic drugs and cardiovascular risk in patients with psoriasis with or without psoriatic arthritis: a nationwide cohort study
Q36253671Atherosclerosis and rheumatoid arthritis: more than a simple association
Q35553376Atherosclerotic cardiovascular disease in rheumatoid arthritis
Q35121150Cardiovascular disease in patients with chronic inflammation: mechanisms underlying premature cardiovascular events in rheumatologic conditions
Q37859676Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity
Q33806651Cardiovascular morbidity and mortality in rheumatoid arthritis
Q82835412Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and a German risk score model
Q37956137Cardiovascular safety of biologic therapies for the treatment of RA.
Q35198206Co-morbidity in rheumatoid arthritis
Q34275967Comorbidity in rheumatoid arthritis.
Q28364851Comparative study of intramuscular gold and methotrexate in a rheumatoid arthritis population from a socially deprived area
Q81346281Diastolic function abnormalities in active rheumatoid arthritis evaluation by conventional Doppler and tissue Doppler: relation with duration of disease
Q40408210Early-onset pancytopenia and skin ulcer following low-dose methotrexate therapy
Q44574975Endothelial dysfunction in young patients with long-term rheumatoid arthritis and low disease activity
Q44016937Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis
Q28190121Homocysteine-lowering treatment: an overview
Q48502988Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis
Q44652560Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis
Q42019607Inflammatory bowel disease of the elderly: a wake-up call
Q38122069Management of the elderly patients with inflammatory bowel disease: practical considerations.
Q37975943Managing cardiovascular risk in patients with chronic inflammatory diseases.
Q44973310Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
Q34757801Methotrexate in atherogenesis and cholesterol metabolism
Q35471696Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells
Q35636960Methotrexate modulates the kinetics of adenosine in humans in vivo
Q27320563Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation
Q35551023Mortality in patients with rheumatoid arthritis treated actively from the time of diagnosis
Q80152218P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters
Q38291820Prediction and management of cardiovascular outcomes in systemic lupus erythematosus
Q28709376Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis
Q36040885Rheumatoid disease and the heart: from epidemiology to echocardiography
Q37640953The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review
Q79394738The effects of folic acid and nitric oxide synthase inhibition on coronary flow and oxidative stress markers in isolated rat heart
Q36596365The heart and cardiovascular manifestations in rheumatoid arthritis
Q34717052Treatment of inflammatory bowel disease in the elderly: an update
Q81881480Use of tissue Doppler and its comparison with other conventional Doppler techniques in the assessment of diastolic functions in patients with active rheumatoid arthritis
Q87636756Use of tissue Doppler and its comparison with other pulse Doppler echocardiography in the evaluation of diastolic functions in patients with active juvenile idiopathic arthritis
Q73559007Ventricular function abnormalities in active rheumatoid arthritis: a Doppler echocardiographic study
Q46407214Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?

Search more.